Routine monitoring of serum calcitonin or using thyroid ultrasound is of uncertain value for early detection of MTC in patients treated with Wegovy Important Safety Information for Wegovy WARNING: RISK OF THYROID C-CELL TUMORS In rodents, semaglutide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures
Zinman B, Bhosekar V, Busch R, et al
A single injection is the primary protocol, with a repeat at 6 weeks if needed
While You Wait: Approved Alternatives Retatrutide is anticipated for FDA approval around 2027, pending Phase 3 results and regulatory review
It's not a mental stress, it's an oxidative stress
When it comes to supporting our health and wellness, the choices we make about supplements can significantly impact our overall well-being